Cue Biopharma Inc.

CUE | NASDAQ

Price Alert Chart Builder DCF Calculator

$26.16

-$2.11 (-7.46%)

Sep 22, 2026, 12:50 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	27.14M	22.46M	48.51M	51.61M	64.37M	74.87M
Short-Term Investments	n/a	929K	n/a	24.68M	n/a	10M
Long-Term Investments	154K	n/a	151K	n/a	150K	n/a
Other Long-Term Assets	760K	2.21M	2.81M	3.39M	2.86M	3.12M
Receivables	7.45M	945K	1.7M	57K	3.14M	1.42M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.4M	805K	1.24M	841K	80K	n/a
Total Current Assets	36.98M	25.14M	51.45M	77.19M	68.47M	87.53M
Property-Plant & Equipment	4.32M	4.84M	7.12M	10.7M	11.92M	8.88M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.23M	7.05M	10.08M	14.1M	14.93M	12.01M
Total Assets	42.21M	32.19M	61.53M	91.28M	83.4M	99.53M
Account Payables	3.95M	2.82M	3.5M	2.73M	2.59M	2.07M
Deferred Revenue	5.34M	n/a	2.11M	n/a	645.35K	6.68M
Short-Term Debt	n/a	4.33M	3.96M	1.96M	1.97M	n/a
Other Current Liabilities	783K	85K	1.92M	2.27M	38.31K	1.96M
Total Current Liabilities	13.49M	13.69M	17.08M	11.55M	12.79M	16.32M
Long-Term Debt	n/a	n/a	4.2M	8.04M	n/a	n/a
Other Long-Term Liabilities	n/a	1	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.29M	1M	7.36M	14.05M	5.12M	4.31M
Total Liabilities	15.78M	14.69M	24.45M	25.6M	17.91M	20.62M
Total Debt	4.2M	8.88M	14.7M	19.32M	12.02M	7.15M
Book Value	26.43M	17.5M	37.09M	65.68M	65.49M	78.91M
Book Value Per Share	8.37	9.32	24.32	55.27	62.80	82.52
Common Stock	97K	62K	47K	43K	32.2K	30.35K
Retained Earnings	-368.47M	-341.86M	-301.19M	-250.46M	-197.45M	-153.29M
Comprehensive Income	n/a	n/a	n/a	-96K	n/a	7.13K
Shareholders Equity	26.43M	17.5M	37.09M	65.68M	65.49M	78.91M
Total Investments	154K	929K	151K	24.68M	150K	10M